Literature DB >> 9627933

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.

F Costa1, G Franchin, V L Pereira-Chioccola, M Ribeirão, S Schenkman, M M Rodrigues.   

Abstract

Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease, does not synthesize sialic acid, but expresses a trans-sialidase that catalyses the transfer of sialic acid from host glycoconjugates to the parasite surface. Several lines of evidence suggest that this enzyme is a virulence factor implicated in the establishment of infection. Here we studied whether immunization with a plasmid DNA containing a gene encoding for the catalytic domain of the enzyme could elicit protective immunity against T. cruzi infection in mice. We observed that immunization with this plasmid DNA generated antibody and T-cell mediated immune responses. Antibodies recognized the native enzyme and inhibited its activity in vitro. Upon challenge with bloodstream trypomastigotes, immunized animals displayed reduced parasitemia and mortality.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627933     DOI: 10.1016/s0264-410x(97)00277-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  35 in total

1.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Sialoglycans in protozoal diseases: their detection, modes of acquisition and emerging biological roles.

Authors:  Anil K Chava; Sumi Bandyopadhyay; Mitali Chatterjee; Chitra Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

Authors:  Adriano F S Araújo; Bruna C G de Alencar; José Ronnie C Vasconcelos; Meire I Hiyane; Cláudio R F Marinho; Marcus L O Penido; Silvia B Boscardin; Daniel F Hoft; Ricardo T Gazzinelli; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Free energy study of the catalytic mechanism of Trypanosoma cruzi trans-sialidase. From the Michaelis complex to the covalent intermediate.

Authors:  Gustavo Pierdominici-Sottile; Nicole A Horenstein; Adrian E Roitberg
Journal:  Biochemistry       Date:  2011-10-27       Impact factor: 3.162

5.  Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells.

Authors:  Pablo Ruiz Díaz; Juan Mucci; María Ana Meira; Yanina Bogliotti; Daniel Musikant; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

6.  Trans-sialidase Protein as a Potential Serological Marker for African Trypanosomiasis.

Authors:  Ana Filipa Teixeira; João Gomes Pereira; Sónia Pestana-Ascensão; Marcelo Sousa Silva
Journal:  Protein J       Date:  2019-02       Impact factor: 2.371

7.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.

Authors:  Nisha Garg; Rick L Tarleton
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

10.  Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.

Authors:  Eduardo L V Silveira; Carla Claser; Filipe A B Haolla; Luiz G Zanella; Mauricio M Rodrigues
Journal:  Clin Vaccine Immunol       Date:  2008-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.